Question 1

Does Skandinaviska Enskilda Banken AB (publ) own KRYS stock?

Accepted Answer

No. Skandinaviska Enskilda Banken AB (publ) exited its KRYS (Krystal Biotech) position in Q1 2026. Its Q4 2025 13F listed 46,732 shares worth $11.5M.

Question 2

How many shares of KRYS does Skandinaviska Enskilda Banken AB (publ) own?

Accepted Answer

None since Q1 2026, when Skandinaviska Enskilda Banken AB (publ) exited the position. Its Q4 2025 13F listed 46,732 shares worth $11.5M.

Question 3

What is Skandinaviska Enskilda Banken AB (publ)'s KRYS position worth?

Accepted Answer

Skandinaviska Enskilda Banken AB (publ)'s KRYS position was worth $11.5M in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is Skandinaviska Enskilda Banken AB (publ) buying or selling KRYS?

Accepted Answer

In Q1 2026, Skandinaviska Enskilda Banken AB (publ) exited its entire KRYS position.

Question 5

When did Skandinaviska Enskilda Banken AB (publ) first buy KRYS?

Accepted Answer

Skandinaviska Enskilda Banken AB (publ) first reported KRYS in its Q1 2021 13F and listed it in 20 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$263.80
2025-Q4	Decreased	46,732	-22.1%	$11.5M	0.0%	$247.88
2025-Q3	Unchanged	59,978	0.0%	$10.6M	0.0%	$176.75
2025-Q2	Unchanged	59,978	0.0%	$8.2M	0.0%	$138.88
2025-Q1	Decreased	59,978	-32.6%	$10.8M	0.1%	$183.92
2024-Q4	Decreased	89,047	-29.4%	$14.2M	0.1%	$159.80
2024-Q3	Decreased	126,082	-34.2%	$23M	0.1%	$177.14